Close
ACHEMA MIDDLE EAST 2026

Key Areas For AI/ML Drug Development – FDA Discussion Paper

A discussion paper has been published by the US FDA that aims at complementing and informing future guidance on artificial intelligence (AI) and machine...

Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

Mettler-Toledo Product Inspection has launched the X2 Series of high-performing x-ray systems to help enhance product safety at an incredible price point for all...

Rising Pharmaceuticals Demand Drives Tablet Coatings Market

The worldwide tablet coatings sector generated $2.2 billion in 2021 and is projected to reach $4.1 billion by 2031, growing at a CAGR of...

Particle Size Distribution Real-Time Monitoring With PEACE

Researchers have gone on to develop a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can go ahead with the extraction of the particle...

Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

Mettler-Toledo Product Inspection is showcasing a wide range of stand-alone and fully-integrated automated smart product inspection systems at Interpack 2023. The advanced product inspection technologies on Booth A60 in...

ABPI and NHS Are in Talks for New Medicines Scheme in the UK

The government of the UK, NHS England, as well as the Association of the British Pharmaceutical Industry have gone on to open new negotiations...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...